Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Interest Coverage Ratio (2021 - 2025)

Fennec Pharmaceuticals (FENC) has disclosed Interest Coverage Ratio for 9 consecutive years, with 0.32 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest Coverage Ratio rose 93.64% year-over-year to 0.32, compared with a TTM value of 1.7 through Sep 2025, down 506.35%, and an annual FY2024 reading of 0.63, up 116.77% over the prior year.
  • Interest Coverage Ratio was 0.32 for Q3 2025 at Fennec Pharmaceuticals, up from 4.6 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 81.82 in Q3 2021 and bottomed at 1230.75 in Q1 2021.
  • Average Interest Coverage Ratio over 5 years is 104.48, with a median of 4.71 recorded in 2024.
  • Peak annual rise in Interest Coverage Ratio hit 301.26% in 2024, while the deepest fall reached 327.17% in 2024.
  • Year by year, Interest Coverage Ratio stood at 81.82 in 2021, then tumbled by 108.2% to 6.71 in 2022, then soared by 70.4% to 1.99 in 2023, then skyrocketed by 51.34% to 0.97 in 2024, then skyrocketed by 66.64% to 0.32 in 2025.
  • Business Quant data shows Interest Coverage Ratio for FENC at 0.32 in Q3 2025, 4.6 in Q2 2025, and 1.36 in Q1 2025.